Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
| NAV as of Oct 20, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
|---|---|---|---|
| ₹34.58+0.46% 1 day change | 21.66% p.a. | App exclusive | ₹830 Cr |
| Expense ratio | 1.04% as on Sep 30, 2025 |
| Exit load | 1.0% Exit load of 1% if redeemed within 30 days.! |
| AUM (Fund size) | ₹830 Cr |
| Lock-in Period | Nil |
| Age | 6 yrs 4 m since Jun 20, 2019 |
| Benchmark | BSE Healthcare TRI |
| Min. investment | SIP: ₹500 & Lumpsum: ₹1000 |
| Risk | Very High |
| Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
| Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
| Period | This fund | Category average |
|---|---|---|
| 1 Month | 1.68% | 2.25% |
| 3 Months | -0.83% | -0.39% |
| 6 Months | 6.21% | 8.17% |
| 1 Year | 1.98% | 5.6% |
| 2 Years | 25.22% | 28.22% |
| 3 Years | 23.35% | 24.61% |
| 4 Years | 14.87% | 16.84% |
| 5 Years | 17.96% | 19.57% |

Large Cap 41.69%
Mid Cap 28.29%
Small Cap 28.36%
Other Cap 0%
Healthcare 95.67%
Services 1.64%
Chemicals 0.99%
Bifurcation by Credit Quality is not available for this fund
Bifurcation by Holding is not available for this fund
Reverse Repo 1.90204401%
Others 1.9%

| Alpha | -0.32 vs. 5.94 Underperformed at beating benchmark |
| Sharpe | 0.95 vs. 4.0 Poor risk-adjusted returns |
| Beta | 0.96 vs. 0.72 More sensitive to market's ups & downs |
| Standard deviation | 16.06 vs. 9.14 More volatile performance |
| Fund AUM | 830 Cr as on Sep 30, 2025 |
| Scheme document | View Scheme Document |
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
| No. of schemes | 89 view all schemes |
| Total AUM | 4,28,066 Cr as on Sep 30, 2025 |
| Address | One World Center, Tower 1, 17th Floor, Jupiter Mill Compound Senapati Bapat Marg, Elphinstone Road Mumbai, 400013 |
| Fund name | ETM Rank | AUM | 1Y | 5Y |
|---|---|---|---|---|
| Aditya Birla Sun Life PSU Equity Fund | N.A. | 5,533 Cr | 4.99% | 35.27% |
| Aditya Birla Sun Life Infrastructure Fund | N.A. | 1,136 Cr | 4.16% | 30.7% |
| Aditya Birla Sun Life Mid Cap Fund | N.A. | 6,008 Cr | 3.25% | 25.6% |
| Aditya Birla Sun Life Small Cap Fund | N.A. | 4,882 Cr | 1.73% | 24.34% |
| Aditya Birla Sun Life Value Fund | N.A. | 6,033 Cr | 0.79% | 24.2% |
| Aditya Birla Sun Life Dividend Yield Fund | N.A. | 1,445 Cr | -0.93% | 23.46% |
The current Net Asset Value (NAV) of the Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Growth plan is approximately ₹34.58 as of Oct 20, 2025.
The Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth is a 6 yrs 4 m old fund and has delivered average annual returns of 21.66% since inception.
| 1-Year | 3-Year | 5-Year | Since Inception |
|---|---|---|---|
| 1.98% | 23.35% | 17.96% | 21.66% |
The Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Growth has an expense ratio of 1.04%, representing the annual cost of managing and operating the fund. This fee is deducted from the fund's AUM while declaring the daily NAV, reducing investor returns.
The Aditya Birla Sun Life Pharma & Healthcare Fund currently has assets under management (AUM) or fund size valued at approximately 830 Cr as on Sep 30, 2025.
The Aditya Birla Sun Life Pharma & Healthcare Fund has invested the majority of its money in the stocks of the following companies -
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceutical Industries Ltd. | 11.17% |
| Apollo Hospitals Enterprise Ltd. | 7.59% |
| Cipla Ltd. | 6.83% |
| Fortis Healthcare Ltd. | 5.58% |
| Abbott India Ltd. | 4.57% |
| Lupin Ltd. | 4.52% |
| Torrent Pharmaceuticals Ltd. | 4.45% |
| Ajanta Pharma Ltd. | 3.75% |
| Ipca Laboratories Ltd. | 3.55% |
| Anthem Biosciences Ltd. | 3.22% |
The Aditya Birla Sun Life Pharma & Healthcare Fund has primarily invested in the following sectors
| Sector | Percentage of Portfolio |
|---|---|
| Healthcare | 95.67% |
| Services | 1.64% |
| Chemicals | 0.99% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
It is very fast, easy, and completely paperless in this mutual fund scheme on ET Money. The whole process takes just a few minutes. Here's how it works:
For the Desktop Version:
For the Mobile Version:
That's it. Your investment in the Aditya Birla Sun Life Pharma & Healthcare Fund is complete.
Redeeming your investments in the Aditya Birla Sun Life Pharma & Healthcare Fund is simple. If you have invested via ET Money, just log in to the app, go to the holdings section, and submit the redemption request.
If you have invested from anywhere else, you can go to the fund house website and put a request through it.
